全文获取类型
收费全文 | 9088篇 |
免费 | 556篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 210篇 |
妇产科学 | 111篇 |
基础医学 | 1287篇 |
口腔科学 | 30篇 |
临床医学 | 860篇 |
内科学 | 2333篇 |
皮肤病学 | 118篇 |
神经病学 | 754篇 |
特种医学 | 351篇 |
外科学 | 1652篇 |
综合类 | 23篇 |
一般理论 | 2篇 |
预防医学 | 375篇 |
眼科学 | 75篇 |
药学 | 585篇 |
中国医学 | 22篇 |
肿瘤学 | 845篇 |
出版年
2023年 | 52篇 |
2022年 | 92篇 |
2021年 | 230篇 |
2020年 | 122篇 |
2019年 | 242篇 |
2018年 | 244篇 |
2017年 | 194篇 |
2016年 | 199篇 |
2015年 | 266篇 |
2014年 | 328篇 |
2013年 | 421篇 |
2012年 | 704篇 |
2011年 | 726篇 |
2010年 | 412篇 |
2009年 | 388篇 |
2008年 | 590篇 |
2007年 | 623篇 |
2006年 | 589篇 |
2005年 | 661篇 |
2004年 | 563篇 |
2003年 | 539篇 |
2002年 | 557篇 |
2001年 | 73篇 |
2000年 | 55篇 |
1999年 | 90篇 |
1998年 | 119篇 |
1997年 | 73篇 |
1996年 | 69篇 |
1995年 | 46篇 |
1994年 | 60篇 |
1993年 | 52篇 |
1992年 | 21篇 |
1991年 | 25篇 |
1990年 | 31篇 |
1989年 | 17篇 |
1988年 | 20篇 |
1987年 | 20篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 14篇 |
1983年 | 13篇 |
1982年 | 12篇 |
1981年 | 16篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1976年 | 9篇 |
1973年 | 7篇 |
1972年 | 10篇 |
1971年 | 6篇 |
1969年 | 6篇 |
排序方式: 共有9688条查询结果,搜索用时 15 毫秒
961.
Thierry A. Folliguet Alain Dibie François Philippe Fabrice Larrazet Michel S. Slama François Laborde 《Journal of robotic surgery》2010,4(4):241-246
Robotically assisted surgery enables coronary surgery to be performed totally or partially endoscopically. Using the Da Vinci
robotic technology allows minimally invasive treatments. We report on our experience with coronary artery surgery in our department:
patients requiring single or double vessel surgical revascularization were eligible. The procedure was performed without cardiopulmonary
bypass on a beating heart. From April 2004 to May 2008, 55 consecutive patients were enrolled in the study, and were operated
on by a single surgical team. Operative outcomes included operative time, estimated blood loss, transfusions, ventilation
time, intensive care unit (ICU) and hospital length of stay. Average operative time was 270 ± 101 min with an estimated blood
loss of 509 ± 328 ml, a postoperative ventilation time of 6 ± 12 h, ICU stay of 52 ± 23 h, and a hospital stay of 7 ± 3 days.
Nine patients (16%) were converted to open techniques, and transfusion was required in four patients (7%). Follow-up was complete
for all patients up to 1 year. There was one hospital death (1.7%) and two deaths at follow-up. Coronary anastomosis was controlled
in 48 patients by either angiogram or computed tomography scan, revealing occlusion or anastomotic stenoses (>50%) in six
patients. Overall permeability was 92%. Major adverse events occurred in 12 patients (21%). One-year survival was 96%. Our
initial experience with robotically assisted coronary surgery is promising: it avoids sternotomy and with a methodical approach
we were able to implement the procedure safely and effectively in our practice, combining minimal mortality with excellent
survival. 相似文献
962.
963.
Enrico Franceschi Roger Stupp Martin J. van den Bent Carla van Herpen Florence Laigle Donadey Thierry Gorlia Monika Hegi Benoit Lhermitte Lewis C. Strauss Anouk Allgeier Denis Lacombe Alba A. Brandes 《Neuro-oncology》2012,14(12):1503-1510
The treatment of patients with recurrent glioblastoma remains a major oncologic problem, with median survival after progression of 7–9 months. To determine the maximum tolerated dose and dose-limiting toxicity (DLT), the combination of dasatinib and cyclonexyl-chloroethyl-nitrosourea (CCNU) was investigated in this setting. The study was designed as multicenter, randomized phase II trial, preceded by a lead-in safety phase. The safety component reported here, which also investigated pharmacokinetics and preliminary clinical activity, required expansion and is therefore considered a phase I part to establish a recommended dosing regimen of the combination of CCNU (90–110 mg/m2) and dasatinib (100–200 mg daily). Overall, 28 patients were screened, and 26 patients were enrolled. Five dose levels were explored. DLTs, mainly myelosuppression, occurred in 10 patients. Grade 3 or 4 neutropenia was recorded in 7 patients (26.9%) and thrombocytopenia in 11 patients (42.3%). No significant effect of CCNU coadministration on dasatinib pharmacokinetics was found. Median progression-free survival (PFS) was 1.35 months (95% confidence interval: 1.2–1.4) and 6-month PFS was 7.7%. In this phase I study of recurrent glioblastoma patients, the combination of CCNU and dasatinib showed significant hematological toxicities and led to suboptimal exposure to both agents. 相似文献
964.
Population genetics of Trypanosoma brucei gambiense,the agent of sleeping sickness in Western Africa
Mathurin Koffi Thierry De Mee?s Bruno Bucheton Philippe Solano Mamadou Camara Dramane Kaba Gérard Cuny Francisco J. Ayala Vincent Jamonneau 《Proceedings of the National Academy of Sciences of the United States of America》2009,106(1):209-214
Human African trypanosomiasis, or sleeping sickness caused by Trypanosoma brucei gambiense, occurs in Western and Central Africa. T. brucei s.l. displays a huge diversity of adaptations and host specificities, and questions about its reproductive mode, dispersal abilities, and effective size remain under debate. We have investigated genetic variation at 8 microsatellite loci of T. b. gambiense strains isolated from human African trypanosomiasis patients in the Ivory Coast and Guinea, with the aim of knowing how genetic information was partitioned within and between individuals in both temporal and spatial scales. The results indicate that (i) migration of T. b. gambiense group 1 strains does not occur at the scale of West Africa, and that even at a finer scale (e.g., within Guinea) migration is restricted; (ii) effective population sizes of trypanosomes, as reflected by infected hosts, are probably higher than what the epidemiological surveys suggest; and (iii) T. b. gambiense group 1 is most likely a strictly clonally reproducing organism. 相似文献
965.
Marie-Germaine Bousser Jean-Luc Elghozi Dominique Laude Thierry Soisson 《Cephalalgia : an international journal of headache》1986,6(4):205-209
Urinary 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were determined in 44 young adult migraine patients (35 women, 9 men) between attacks and in 33 healthy controls (23 women, 10 men). HVA excretion was equivalent in all groups. 5-HIAA was unaltered in men but was significantly decreased in female migraine patients when compared with their sex-matched controls (-31%, p less than 0.01). No relationship was found between 5-HIAA excretion and the various characteristics of migraine, such as the time that had elapsed since the last attack and the presence or absence of oral contraception. The relatively marked decrease in 5-HIAA excretion in female migraine patients can hardly be accounted for by a reduction in either neuronal or platelet serotonin metabolism alone. A reduction in the intestinal contribution to urinary 5-HIAA might be the crucial factor. 相似文献
966.
967.
968.
969.
Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes. 总被引:1,自引:0,他引:1
Nadège Blanchard Lysiane Richert Brigitte Notter Frederic Delobel Pascale David Philippe Coassolo Thierry Lavé 《European journal of pharmaceutical sciences》2004,23(2):189-199
The objective of the present study was to compare two configurations of the hepatocyte model namely suspensions (SH) and conventional primary cultures (CPC) for their ability to predict the hepatic clearance in vivo in the rat and, to investigate the impact of serum on the prediction accuracy. The metabolic competences of several cytochrome P450 isoenzymes were investigated both in CPC and SH in the presence or absence of serum. Under the same conditions, the in vitro intrinsic clearance of six test compounds metabolised by a variety of phase I and phase II enzymes (antipyrine, RO-X, mibefradil, midazolam, naloxone and oxazepam) were derived from Vmax/Km scaled up to the corresponding in vivo hepatic metabolic clearance. CYP activities were shown to be stable in both CPC and SH for up to 6 h of incubation, except for the CYP 3A1 activity that decreased in CPC even in the presence of serum. Moreover, the clearances predicted from SH in the presence of serum were closer to the in vivo values than those obtained from CPC. SH represent a convenient model to assess the hepatic metabolism of xenobiotics, the presence of serum in the incubation medium significantly improved in several instances the quality of the predictions. 相似文献
970.